Daniel G. Darazsdi

This profile gathers the share dealings of Daniel G. Darazsdi across 2 companies, led by Pharmaceutical Product Development Inc and Cytec Industries Inc/de/. Between 1 October 2007 and 9 December 2015, the trades on record add up to 13 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 11 December 2015, reports a transaction of €339k in Cytec Industries Inc/de/. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.